sdz pco 400 has been researched along with diazoxide in 2 studies
| Studies (sdz pco 400) | Trials (sdz pco 400) | Recent Studies (post-2010) (sdz pco 400) | Studies (diazoxide) | Trials (diazoxide) | Recent Studies (post-2010) (diazoxide) |
|---|---|---|---|---|---|
| 24 | 0 | 3 | 2,923 | 86 | 445 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andres, H; Bray, K; Manley, PW; Quast, U | 1 |
| Dunne, MJ; Finch, A; Harding, EA | 1 |
2 other study(ies) available for sdz pco 400 and diazoxide
| Article | Year |
|---|---|
Synthesis of and radioligand binding studies with a tritiated pinacidil analogue: receptor interactions of structurally different classes of potassium channel openers and blockers.
Topics: Animals; Binding Sites; Drug Interactions; Guanidines; Muscle, Smooth, Vascular; Pinacidil; Potassium Channels; Pyridines; Rats; Structure-Activity Relationship; Vasodilator Agents | 1993 |
Blockade of K+ channels in insulin-secreting cells by the 'potassium channel opener' SDZ PCO 400.
Topics: Animals; Benzopyrans; Cell Membrane; Cyclopentanes; Diazoxide; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Potentials; Phentolamine; Potassium Channel Blockers; Potassium Channels; Rats; Tolbutamide | 1993 |